OTC : CBDL
$0.0 (-66.67%)
OTC
Lisa Anne Nelson
Drug Manufacturers - Specialty & Generic
Healthcare
CBDL
3
US
USD
0.00
15.12
14.21
8.61
0.00
$98321
2.73
0.54
2.40
0.00
$0
-$48929
-39.99%
-39.99%
-4.73%
-3.42%
-14.93
-0.15
-0.15
1/5
2 Analysts
%
About CBD Life Sciences Inc. (OTC:CBDL) Stock
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona. ...
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free
2026-05-05 07:00:00
The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / May 5, 2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to announce our latest product CBD Pouches that are Nicotine Free.
2026-04-22 07:00:00
SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding Inc. Under the terms of this agreement, CBD Life Sciences Inc. has purchased 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel. This strategic acquisition ensures that both Mushroom Madness Inc. and Formrunner Apparel are now fully wholly owned subsidiaries of CBD Life Sciences Inc. (CBDL).
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Patches
2026-04-21 07:00:00
The CBD product industry in 2026 is projected to generate tens of billions in revenue globally, most commonly estimated around $12-20 billion, with strong growth momentum. Growth is driven by: Wellness products (oils, gummies, topicals) Medical uses (pain, anxiety, epilepsy) Increasing consumer acceptance and retail availability SCOTTSDALE, AZ / ACCESS Newswire / April 21, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the launch of our New CBD Patches.
Frequently Asked Questions
What is the current CBD Life Sciences Inc. (CBDL) stock price?
CBD Life Sciences Inc.(OTC:CBDL) stock price is $0.0001 in the last trading session. During the trading session, CBDL stock reached the peak price of $0.001 while $0.0001 was the lowest point it dropped to. The percentage change in CBDL stock occurred in the recent session was --66.67% while the dollar amount for the price change in CBDL stock was -$0.0.
CBDL's industry and sector of operation?
The OTC listed CBDL is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of CBDL?
Matthew McGee
| Chief Marketing Officer
Lisa Anne Nelson
| Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer & Director
Brianna Nelson
| Chief Product Developer & Director
|
|
How many employees does CBDL have?
Number of CBDL employees currently stands at 3. CBDL operates from 10953 N. Frank Lloyd Wright Boulevard, Scottsdale, AZ 85259, US.
Link for CBDL official website?
Official Website of CBDL is: https://www.thecbdvault.com
How do I contact CBDL?
CBDL could be contacted at phone #480 410 6780 and can also be accessed through its website. CBDL operates from 10953 N. Frank Lloyd Wright Boulevard, Scottsdale, AZ 85259, US.
How many shares of CBDL are traded daily?
The average number of CBDL shares traded daily for last 3 months was 20.15M.
What is the market cap of CBDL currently?
The market value of CBDL currently stands at $187.7K with its latest stock price at $0.0001